G6PD Neonatal Screen Dried blood spot in Ahmedabad
50+ booked in last 3 daysOverview
This test checks for G6PD Deficiency in the newborn using G6PD as the marker analyte.
The G6PD Neonatal Screen Dried Blood Spot test checks for G6PD deficiency in newborns. It is a type of blood test that is commonly performed on babies shortly after birth as part of routine newborn screening.
G6PD deficiency can cause hemolytic anemia, which is a condition in which the body destroys red blood cells at a faster rate than it can produce them. This can cause a range of symptoms, including jaundice, fatigue, and shortness of breath. Early detection and treatment of G6PD deficiency can help prevent serious complications and improve the baby's overall health.
Associated Tests:
G6PD Qualitative Blood
G6PD Quantitative Reflex Qualitative
G6pd Gene Mutation
Neoxpert IAP (Newborn Screening 3 Analytes)
Neoxpert 5 (Newborn Screening 5 Analytes)
Neoxpert 8 (Newborn Screening 8 Analytes)
Neoxpert by TMS (Newborn Screening 40+ Analytes)
Neoxpert Expanded Screening Panel (Newborn Screening 48+ Analytes)
Anaemia Profile-Maxi
Anaemia Profile-Haemolytic Type
Written by : Supriya Kulkarni, Lead-Content & Training
G6PD Neonatal Screen Dried blood spot Price in Ahmedabad
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the G6PD Neonatal Screen Dried blood spot with a clear pricing structure
The price of G6PD Neonatal Screen Dried blood spot in Ahmedabad is ₹ 500
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
To identify at-risk babies for G6PD enzyme deficiency at the earliest.
This is a screening test for newborn babies usually done within 48-72 hours of birth to detect inborn errors of metabolism.
Newborn Screening is a test that involves testing of infants at birth for certain genetically linked metabolic disorders which may affect baby’s physical, mental and intellectual development. This test checks for G6PD Deficiency in the newborn using G6PD as the marker analyte.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.